Market cap
₹390 Cr
Revenue (TTM)
₹4,242 Cr
P/E Ratio
1.7
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 3.59 | 5.12 | 5.92 |
| EBIT | -- | -- | 3.74 | 19.75 | 18.46 |
| Net Profit | -- | -- | 2.63 | 14.34 | 36.89 |
| EPS | -- | -- | 2.63 | 14.34 | 36.89 |
| Book Value | -- | -- | 1.56 | 7.31 | 10.42 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 20.98 | 18.98 | 23.00 | 22.96 | 16.98 |
| Net Margin
| 22.84 | 21.47 | 23.86 | 24.12 | 20.56 |
| Return on equity
| 17.34 | 16.78 | 17.48 | 18.31 | 16.22 |
| Return on Capital
| 19.80 | 18.11 | 20.61 | 21.54 | 17.26 |
| Return on Assets
| 13.73 | 12.91 | 13.78 | 14.57 | 12.85 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
20.61
Higher than Peers by 5.71
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
20.61
|
21.54
|
17.26
|
14.86
|
16.29
|
|
Peer Median
|
14.90
|
14.72
|
18.85
|
11.60
|
--
|
ROE
17.48
Higher than Peers by 4.71
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
17.48
|
18.31
|
16.22
|
15.17
|
16.69
|
|
Peer Median
|
12.77
|
11.67
|
14.92
|
11.46
|
--
|
ROA
13.78
Higher than Peers by 6.69
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
13.78
|
14.57
|
12.85
|
11.82
|
11.55
|
|
Peer Median
|
7.09
|
7.86
|
9.06
|
6.44
|
--
|
EBIT Margin
23.00
Higher than Peers by 8.93
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
23.00
|
22.96
|
16.98
|
15.56
|
16.42
|
|
Peer Median
|
14.07
|
15.03
|
14.71
|
12.37
|
--
|
Net Margin
23.86
Higher than Peers by 15.31
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
23.86
|
24.12
|
20.56
|
19.20
|
19.64
|
|
Peer Median
|
8.54
|
9.33
|
8.49
|
10.02
|
--
|
Cash Profit Margin
37.48
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
37.48
|
39.55
|
36.52
|
35.44
|
36.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
3.59
Lower than Peers by 9.45
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
3.59
|
5.00
|
6.80
|
5.16
|
9.12
|
|
Peer Median
|
13.04
|
10.27
|
11.85
|
9.08
|
--
|
EBIT Growth
3.74
Lower than Peers by 13.43
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
3.74
|
42.00
|
16.58
|
-0.39
|
36.38
|
|
Peer Median
|
17.18
|
24.15
|
28.00
|
-3.12
|
--
|
Net Profit Growth
2.63
Lower than Peers by 22.21
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
2.63
|
24.70
|
16.80
|
4.56
|
207.50
|
|
Peer Median
|
24.83
|
30.29
|
36.51
|
-0.85
|
--
|
EPS Growth
2.63
Lower than Peers by 15.18
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
2.63
|
24.70
|
16.80
|
4.56
|
207.50
|
|
Peer Median
|
17.80
|
24.50
|
--
|
-6.82
|
--
|
Book Value Growth
1.56
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
1.56
|
14.29
|
6.45
|
12.34
|
18.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.21
|
0.23
|
0.20
|
0.15
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.42
Higher than Peers by 0.56
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
2.42
|
2.63
|
1.27
|
1.57
|
2.01
|
|
Peer Median
|
1.86
|
1.79
|
1.96
|
2.08
|
--
|
Quick Ratio
2.10
Higher than Peers by 0.90
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
2.10
|
2.28
|
0.92
|
1.16
|
1.46
|
|
Peer Median
|
1.20
|
1.47
|
1.44
|
1.58
|
--
|
Interest Coverage
4,284.67
Higher than Peers by 4,276.50
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
4,284.67
|
3,124.00
|
1,510.00
|
1,190.50
|
1,270.83
|
|
Peer Median
|
8.17
|
9.42
|
8.58
|
15.41
|
--
|
Operating Efficiency
Debtors to sales
5.29
Lower than Peers by 19.86
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
5.29
|
8.25
|
7.63
|
7.35
|
7.29
|
|
Peer Median
|
25.14
|
25.82
|
26.12
|
22.96
|
--
|
Asset Turnover
0.54
Lower than Peers by 0.19
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
0.54
|
0.57
|
0.59
|
0.60
|
0.58
|
|
Peer Median
|
0.73
|
0.75
|
0.77
|
0.65
|
--
|
Receivable days
24.08
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
24.08
|
28.12
|
26.48
|
25.86
|
24.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
38.96
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
38.96
|
36.85
|
37.73
|
47.43
|
52.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
234.34
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
234.34
|
255.92
|
203.09
|
222.54
|
240.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-171.30
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Zydus Healthcare
|
-171.30
|
-190.95
|
-138.89
|
-149.25
|
-162.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|